Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Euterpe oleracea extract, derived from the açai palm fruit native to the Amazon region, is a botanical substance investigated for its cardiovascular and metabolic benefits. It contains a variety of bioactive compounds, including anthocyanins, flavonoids, and phytosterols. Research, particularly in animal models of atherosclerosis, suggests that the extract can improve lipid profiles by reducing total cholesterol, non-HDL cholesterol, and triglycerides. Its mechanism of action involves modulating the balance between cholesterol absorption and endogenous synthesis, as evidenced by changes in plasma sterol ratios (e.g., desmosterol to campesterol). Beyond its lipid-lowering effects, it demonstrates anti-inflammatory and antioxidant properties that contribute to the attenuation of atherosclerotic plaque development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on euterpe oleracea extract.